Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...

Podrobná bibliografie
Hlavní autoři:	Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J
Médium:	Journal article
Jazyk:	English
Vydáno:	1998

Podobné jednotky

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Autor: Florakis, D, a další
Vydáno: (2000)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
Autor: Monson, J, a další
Vydáno: (2001)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
Autor: Frajese, G, a další
Vydáno: (2001)

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Autor: Chung, T, a další
Vydáno: (2008)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
Autor: Agha, A, a další
Vydáno: (2007)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
Autor: le Roux, C, a další
Vydáno: (2002)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
Autor: Colson, A, a další
Vydáno: (2008)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Autor: Chung, T, a další
Vydáno: (2005)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Autor: Kaltsas, G, a další
Vydáno: (2001)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
Autor: Korbonits, M, a další
Vydáno: (1996)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
Autor: Sverrisdóttir, Y, a další
Vydáno: (2003)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
Autor: Jenkins, P, a další
Vydáno: (2000)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
Autor: Colson, A, a další
Vydáno: (2006)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
Autor: Irene K Oglesby, a další
Vydáno: (2023-09-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
Autor: Korbonits, M, a další
Vydáno: (1999)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
Autor: Korbonits, M, a další
Vydáno: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
Autor: Trainer, P, a další
Vydáno: (1992)

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
Autor: Kaltsas, G, a další
Vydáno: (2003)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
Autor: Alexandraki, K, a další
Vydáno: (2009)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Autor: Kaltsas, G, a další
Vydáno: (2000)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
Autor: Isabella Naves Rosa, a další
Vydáno: (2021-03-01)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
Autor: Sohaib, SA, a další
Vydáno: (1999)

Complications of inferior petrosel sinus sampling.
Autor: Kaltsas, G, a další
Vydáno: (2000)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects.
Autor: Lara Pena-Bello, a další
Vydáno: (2016-01-01)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
Autor: Korbonits, M, a další
Vydáno: (1995)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
Autor: Han Hyuk Lim, a další
Vydáno: (2010-10-01)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
Autor: Swords, F, a další
Vydáno: (2009)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
Autor: Kaltsas, G, a další
Vydáno: (1998)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Autor: Isidori, A, a další
Vydáno: (2003)

Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
Autor: Hugo L. Fideleff, a další
Vydáno: (2016-02-01)

Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Autor: Newell-Price, J, a další
Vydáno: (2002)

NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
Autor: Costa, A, a další
Vydáno: (1992)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Autor: Korbonits, M, a další
Vydáno: (1998)

A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
Autor: Miraki-Moud, F, a další
Vydáno: (2005)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
Autor: Kaltsas, G, a další
Vydáno: (1999)

Initial response of young people with thyrotoxicosis to block and replace or dose titration thionamide
Autor: Claire L Wood, a další
Vydáno: (2023-01-01)

Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
Autor: Mukherjee, J, a další
Vydáno: (1997)

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
Autor: Trainer, P, a další
Vydáno: (1992)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
Autor: Chung, T, a další
Vydáno: (2010)

Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.
Autor: Costa, A, a další
Vydáno: (1993)